Symyx expands lab automation tools
Symyx Technologies has released a machine designed to automate the sample preparation stage of active pharmaceutical ingredient (API) solubility experiments, saving researchers valuable time.
Symyx Technologies has released a machine designed to automate the sample preparation stage of active pharmaceutical ingredient (API) solubility experiments, saving researchers valuable time.
The US Food and Drug Administration (FDA) is following the growing pharma industry trend by embracing outsourcing as part of a cost-saving drive - a move that is attracting strong opposition.
The UK's drug reimbursement watchdog has given the green light for the first time to a treatment specifically for multiple sclerosis (MS) and also gave the thumbs up to two arthritis drugs, all of which are biologics.
Amgen is rushing to discover how interleukin-17 causes inflammation and bone destruction in rheumatoid arthritis, as it could provide a valuable new therapeutic target.
A new guide on the prickly issue of electronic data archiving has been published for the pharmaceutical manufacturing industry, the latest offering from the International Society for Pharmaceutical Engineering (ISPE).
A study of 50 pharmaceutical lines has uncovered 'substantial gaps' in performance between the more operationally savvy and those with less nous.
Novartis is to pull millions of planned investment dollars out of India in reaction to intellectual property (IP) fears. The decision may leave China as the cat that got the cream.
The US market for liquid chromatography is looking 'very promising', according to a new report.